Allergan India Ltd.

Allergan India is the market leader in the Indian Ophthalmology business with a 17.4 per cent market share*. The company continues to play a pioneering role in developing the ophthalmology market in the country through its marketing programs and service to the ophthalmic community.

Allergan's major initiatives for the Indian market include improving awareness, diagnosis and treatment of Glaucoma in the country, one of the leading causes of irreversible blindness. Developing the treatment of ocular surface disease/dry eye, the incidence of which is on the increase due to environmental problems, and introducing new surgical products, particularly in small incision cataract surgery, where it is the market leader. Its range of pharmaceutical products grew 19 % during the current financial year, well above the industry growth.

Allergan's goal is to provide the India practitioners and consumers with the latest advances in technology. The focus is on continually upgrading products and services and building a strong well-trained organization to meet future needs.

The company achieved a turnover of Rs. 76.53 crores in 2003. Profit After Tax was being Rs. 8.43 crores.

*Source: ORG